Cat.#: ASSD-165
| Description | FLUO 3-AM is a cell-permeable Ca2+ sensitive fluorescent indicator (Kd = 0.36 µM) that can metabolize into FLUO-3 by cytoplasmic esterases. |
| Size | 1 mg |
| Molecule Weight | 1129.85 |
| Molecular formula | C51H50Cl2N2O23 |
| CAS Number | 121714-22-5 |
| PubChem identifier | 5086914 |
| Purity | >85% |
| Solubility | Soluble in DMSO (0.9mg/ml) or water |
| Storage | +4°C or -20°C long-term. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-113 | Thionin acetate salt (AC113) | 5 g | inquiry |
| ASSD-153 | Brilliant Blue G (AC153) | 1g | inquiry |
| ASSD-135 | JC-1 (AC135) | 5 mg | inquiry |
| ASSD-106 | Hoechst 33342 Staining Solution (10mg/ml) (AC106) | 5 mL, 10 mL | inquiry |
| ASSD-166 | FURA-2 (AC166) | 1 mg | inquiry |
| ASSD-125 | Fluorescent D1 antagonist [SKF83566-green] (AC125) | 50 μg | inquiry |
| ASSD-204 | 7-Diethylamino-3-[N-(2-maleimidoethyl)carbamoyl]coumarin (AC204) | 1 mg, 5 mg | inquiry |
| ASSD-173 | FITC-Dextran 70 (AC173) | 100 mg, 500 mg | inquiry |
| ASSD-121 | Fluorescent adenosine A3 antagonist [XAC] (AC121) | 500 μg | inquiry |
| ASSD-119 | Fluorescent adenosine agonist [NECA] (AC119) | 500 μg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.